首页 正文

Cost-effectiveness of ruxolitinib in Singapore for patients with chronic graft-versus-host disease

{{output}}
Objective: To evaluate the cost-effectiveness of ruxolitinib in Singapore for patient with chronic graft-versus-host disease (GVHD) and inadequate response to corticosteroids. ... ...